EPS Creative Health Technology Group Limited

EPS Creative Health Technology Group Limited

HHKEX:3860
0.58
HKD
-0.02
(-3.33%)
0.07EPS
7.77P/E
270.00MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.8
0.87
1.15
0.81
0.87
1.07
0.81
1.04
0.91
1.29
1.05
0.88
1.08
Basic EPS, GAAP
0.02
0.02
0.02
0.03
0.05
0.05
0.01
-0.05
-0.09
-0.04
0.07
-0.03
0.07
Free Cash Flow per Basic Share
0.06
0.02
0.04
0.05
- -
0.05
-0.03
0.01
-0.08
-0.07
-0.05
0.05
- -
Dividend per Share
0.01
- -
- -
- -
0.02
0.02
- -
- -
- -
- -
- -
0.01
- -
Book Value per Share
0.08
0.04
0.05
0.18
0.22
0.25
0.27
0.26
0.18
0.13
0.23
0.2
0.25
Tangible Book Value per Share
0.08
0.04
0.05
0.18
0.22
0.25
0.27
0.26
0.18
-0.28
0.05
0.03
0.25
Basic Weighted Avg Shares
500
500
375
479
500
500
500
500
500
500
521
522
500
Sales/Revenue/Turnover
398
435
430
390
433
537
405
520
453
645
545
458
538
Operating Margin (%)
4.01
4.41
5.04
4.57
7.32
4.98
2.09
-2.77
-9.04
-4.47
-1.55
0.17
7.66
Depreciation Expense
2
2
1
1
1
2
3
4
4
14
16
17
- -
Net Income, GAAP
11
12
6
14
27
23
7
-23
-46
-22
39
-14
35
Effective Tax Rate (%)
16.55
21.27
32.87
18.63
16.77
18.22
8.84
- -
- -
- -
9.04
- -
17.23
Profit Margin (%)
2.65
2.86
1.42
3.61
6.29
4.23
1.6
-4.35
-10.1
-3.42
7.09
-3.03
6.46
Working Capital
-7
18
24
91
109
122
129
202
102
7
152
96
119
LT Debt
- -
- -
- -
- -
- -
1
- -
2
- -
2
1
2
2
Total Equity
38
19
25
92
112
127
133
140
92
138
163
153
123
Return on Invested Capital (%)
- -
29.61
35.85
22.73
26.21
22.01
4.98
- -
- -
- -
22.99
- -
28.01
Return on Capital (%)
- -
26.68
17.56
20.45
26.68
18.9
5
- -
- -
- -
34.08
- -
30.59
Return on Common Equity (%)
- -
43.67
27.22
23.93
26.67
19.07
5.01
-17.09
-41.78
-28.85
41.48
-12.22
31.81

Capital Structure

HKD

•

in mil. unless spec.
Mar'19
Jun'20
Sep'20
ST Debt
- -
- -
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
500
500
500
Market Capitalization
240
300
270

Working Capital

HKD

•

in mil. unless spec.
Mar'19
Jun'20
Sep'20
Total Current Assets
141
- -
261
Cash, Cash Equivalents & STI
78
- -
71
Accounts Receivable, Net
9
- -
147
Inventories
4
- -
26
Total Current Liabilities
32
- -
143
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
1
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
36.69%
6.59%
-6.03%
Free Cash Flow
62.12%
-313.12%
-206.28%
Net Income, GAAP
-72.21%
-161.51%
-135.89%
Sales/Revenue/Turnover
2.63%
5.24%
-15.95%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
645
2025
- -
- -
545
2026
- -
- -
458

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.04
2025
- -
- -
0.07
2026
- -
- -
-0.03

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
0.01

Company Description

CEO
Kenichiro Washikita
Full Time Employees
133
Sector
Consumer non-durables
Industry
Apparel/Footwear
Address
Gemstar Tower Hong Kong Hong Kong
IPO Date
May 31, 2017
Website
epshk.hk
Business
EPS Creative Health Technology Group Limited (3860.HK), an investment holding company and subsidiary of Japan's EPS Holdings Inc. since April 2021, provides apparel supply chain management solutions focused on knitwear and trades healthcare products across Asia. Founded in 1999 and headquartered at Room 3301, West Tower, Shun Tak Centre in Sheung Wan, Hong Kong, the company operates through garment, healthcare products, and investor relations with CRO and in-house R&D segments, serving apparel retail brands and sourcing agents primarily in the US, Japan, Mainland China, Europe and internationally. Its core offerings encompass one-stop apparel services including fashion trend analysis, product design and development, material sourcing and procurement, production management, quality control, and logistics for womenswear such as pullovers, cardigans, vests and skirts; menswear and kidswear knitwear products; healthcare trading of beauty products, health foods and cosmetics from Japanese manufacturers targeting China and Southeast Asia; new drug development, research, licensing, financing support, and medical consultancy services. The company, formerly Speed Apparel Holding Ltd., changed its name in August 2021 to reflect its healthcare expansion; in February 2025, its subsidiary EPS Healthcare Limited entered a capital and business alliance with BioBeaute Co. Ltd. to accelerate cosmetics and healthcare expansion into Asia via complementary R&D, contract manufacturing and market entry support; and in March 2025, it disposed of wholly-owned subsidiary EPS Innovative Medicine (Hong Kong) Limited, contributing to an expected profit of HK$30 million for the year ending March 31, 2025, versus a prior-year loss of HK$26.5 million.